Sugi Predict

Sugi Predict / Compounds / SCHEMBL732208

SCHEMBL732208

SCHEMBL732208

c1ccc2nc3c(ccc4ccccc43)cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ HPGD P15428 3/20 0.58
▸ GLA P06280 2/20 0.58
▸ MAPT P10636 2/20 0.58
▸ ACHE P22303 1/20 0.58
▸ HTR3A P46098 1/20 0.48
▸ MAOA P21397 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ CYP2A6 P11509 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ATM Q13315 1/20 0.45
▸ HIF1A Q16665 1/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30141893 1.00 ALDH1A1 (0.58) ALDH1A1HPGDGLAMAPTACHE
Hydrochloric Acid SCHEMBL8321996 0.98 ALDH1A1 (0.56) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL18631801 0.98 ALDH1A1 (0.56) ALDH1A1HPGDGLAMAPTACHE
Isothiocyanate SCHEMBL28570015 0.89 ALDH1A1 (0.47) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL4360083 0.86 ALDH1A1 (0.55) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL29563642 0.86 ALDH1A1 (0.55) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL4902020 0.86 ALDH1A1 (0.70) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL29376631 0.86 ALDH1A1 (0.52) ALDH1A1HPGDGLAMAPTACHE
SCHEMBL19036073 0.85 MAOA (0.45) ALDH1A1HPGDGLAMAPTACHE
Phenanthrene SCHEMBL27653554 0.84 ALDH1A1 (0.75) ALDH1A1HPGDGLAMAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 — — US claimed
US-11594687-B2 Organic electroluminescent device NOVALED GMBH (DE) 2023-02-28 — — US claimed
CN-110892545-B Organic electronic device and apparatus comprising an organic semiconductor layer 诺瓦尔德股份有限公司 2022-12-20 — — CN claimed
EP-3147962-B1 ORGANIC ELECTROLUMINESCENT DEVICE NOVALED GMBH (DE) 2021-04-21 — — EP claimed
US-10937966-B2 Method for preparing an organic semiconductor layer and an organic electronic device NOVALED GMBH (DE) 2021-03-02 — — US claimed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 — — US claimed
CN-108352456-B Organic electroluminescent device 诺瓦尔德股份有限公司 2020-03-20 — — CN claimed
CN-110892545-A Organic electronic device and apparatus comprising an organic semiconductor layer 诺瓦尔德股份有限公司 2020-03-17 — — CN claimed
US-20190207116-A1 Method for Preparing an Organic Semiconductor Layer and an Organic Electronic Device NOVALED GMBH (DE) 2019-07-04 — — US claimed
US-20190058123-A1 Organic Electroluminescent Device NOVALED GMBH (DE) 2019-02-21 — — US claimed
EP-1380575-A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds Maruishi Pharmaceutical Co., Ltd. (JP) 2004-01-14 — — EP claimed
JP-3172522-B2 — — 2001-06-04 — — JP claimed
US-5338847-A Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation LONDON DIAGNOSTICS, INC. (US) 1994-08-16 — — US claimed
US-5321136-A Peri substituted fused ring chemiluminescent labels and their conjugates, and assays therefrom LONDON DIAGNOSTICS, INC. (US) 1994-06-14 — — US claimed
US-5290936-A Indicators or labels for antibodies or medical diagnosis LONDON DIAGNOSTICS, INC. (US) 1994-03-01 — — US claimed
US-5284951-A Aryl ester, thioester or amide of carboxylic acid substituted heterocyclic ring; quaternary compounds LONDON DIAGNOSTICS, INC. (US) 1994-02-08 — — US claimed
US-5281712-A Ammonium substituted chemiluminescent labels and their conjugates, and assays therefrom LONDON DIAGNOSTICS, INC. (US) 1994-01-25 — — US claimed
EP-0332190-A2 Condensed quinoline system compound, condensed acridine system compound, process for preparing the same, and carcinostatic composition containing the same MECT CORPORATION (JP) 1989-09-13 — — EP claimed
WO-1989006231-A1 ASSAYS UTILIZING IMPROVED CHEMILUMINESCENT ESTERS, THIOESTERS AND AMIDES LONDON DIAGNOSTICS, INC. (US) 1989-07-13 — — WO claimed
EP-0322926-A2 Assays utilizing improved chemiluminescent esters, thioesters and amides LONDON DIAGNOSTICS, INC. (US) 1989-07-05 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 ALDH1A1 887/4885HPGD 4229/4885GLA 3067/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 ALDH1A1 887/4885HPGD 4229/4885GLA 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.